Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord

Malessa, S; Leigh, P N; Bertel, O; Sluga, E; Hornykiewicz, O
November 1991
Journal of Neurology, Neurosurgery & Psychiatry;Nov1991, Vol. 54 Issue 11, p984
Academic Journal
journal article
No abstract available.


Related Articles

  • BATTLING DISEASE WITH THE AMINO FACTOR. Maleskey, Gale // Prevention;May89, Vol. 41 Issue 5, p61 

    Reports on the effects of amino acids in fighting amyotrophic lateral sclerosis (ALS). Activation of the body's metabolic processes; Need for large doses of the amino acids leucine, isoleucine and valine; Stimulation of the breakdown of glutamate by the amino acids; Raising of the brain levels...

  • Differential gene expression in human spinal cord tissues from ALS patients. Dangond, Fernando; Brown, Robert; Gullans, Steven R. // Nature Genetics;Nov99 Supplement, Vol. 23, p40 

    Presents an abstract for the article on the differential gene expression in human spinal cord tissues from amyotrophic lateral sclerosis patients.

  • Antibiotics that protect the brain. Secko, David // CMAJ: Canadian Medical Association Journal;2/15/2005, Vol. 172 Issue 4, p467 

    Focuses on a study which analyzed the therapeutic use of some antibiotics against nerve damage associated with diseases, such as amyotrophic lateral sclerosis, dementia, stroke and epilepsy. Mechanism of action of amino acid glutamate; Function and importance of excitatory amino acid...

  • The role of d-amino acids in amyotrophic lateral sclerosis pathogenesis: a review. Paul, Praveen; Belleroche, Jacqueline // Amino Acids;Nov2012, Vol. 43 Issue 5, p1823 

    A potential role for d-amino acids in motor neuron disease/amyotrophic lateral sclerosis (ALS) is emerging. d-Serine, which is an activator/co-agonist at the N-methyl- d-aspartate glutamate receptor subtype, is elevated both in spinal cord from sporadic cases of ALS and in an animal model of...

  • Unaltered cytochrome oxidase, glutamate dehydrogenase and glutaminase activities in platelets from patients with Sporadic Amyotrophic Lateral Sclerosis : A study of potential pathogenetic mechanisms in neurodegenerative diseases. Gluck, M. R.; Thomas, R. G.; Sivak, M. A. // Journal of Neural Transmission;Dec2000, Vol. 107 Issue 12, p1437 

    Summary. Sporadic Amyotrophic Lateral Sclerosis (SALS) is a fatal neurologic disease characterized by degeneration of motor neurons in the spinal cord, brainstem and cortex. While familial cases of ALS exist, the sporadic form accounts for the majority of adult-onset cases. It has been...

  • System xC− is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Mesci, Pinar; Zaïdi, Sakina; Lobsiger, Christian S.; Millecamps, Stéphanie; Escartin, Carole; Seilhean, Danielle; Sato, Hideyo; Mallat, Michel; Boillée, Séverine // Brain: A Journal of Neurology;Jan2015, Vol. 138 Issue 1, p53 

    Microglia have been implicated in amyotrophic lateral sclerosis (ALS) progression, but the underlying mechanisms are unclear. Mesci et al. reveal that suppression of system xC− (a cystine/glutamate transporter) reduces microglia-triggered glutamate excitotoxicity and switches microglia to...

  • Motor neuron disease.  // Journal of Neurology;May2006 Supplement 2, Vol. 253, pII29 

    The article presents abstracts of medical research related to motor neuron diseases. They include "Aggressive familial motor neuron disease associated with GCT to GCA substitution on codon 140 of SOD1 gene," "Diffusion tensor magnetic resonance imaging of the spinal cord in amyotrophic lateral...

  • Amyotrophic Lateral Sclerosis.  // Encyclopedic Reference of Molecular Pharmacology;2004, p32 

    The article presents an encyclopedia entry for amyotrophic lateral sclerosis. It is a disease of motor neurons, in which both the upper motor neurons in the cortex and the lower motor neuron in the brain stem and spinal cord degenerate progressively, leading to neurogenic atrophy of muscle...

  • Pakistani-American Scientist Leads Major ALS Breakthrough.  // News India Times;09/02/2011, Vol. 42 Issue 35, p11 

    The article reports on the study headed by Pakistani-American Dr. Teepu Siddique accounting amyotrophic lateral sclerosis (ALS) to the broken down protein recycling system in the brain and spinal cord neurons.

  • Does neuroprotection really work in glaucoma patients? Guttman, Cheryl; Girkin, Christopher A. // Ophthalmology Times;02/15/2001, Vol. 26 Issue 4, p32 

    Explores the treatment for glaucoma using neuroprotection strategy. Efficacy of neuroprotection in neurologic diseases; Investigations concerning neuroprotective strategies in stroke, spinal cord injury, and neurodegenerative diseases; Results of using neuroprotectants in spinal cord injury and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics